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Recommended Laboratory HIV Testing Algorithm for Serum or Plasma Specimens 
 
1. Laboratories should conduct initial testing for HIV with an FDA-approved antigen/antibody 
combination immunoassay* that detects HIV-1 and HIV-2 antibodies and HIV-1 p24 antigen to screen 
for established infection with HIV-1 or HIV-2 and for acute HIV-1 infection. No further testing is 
required for specimens that are nonreactive on the initial immunoassay. 
2. Specimens with a reactive antigen/antibody combination immunoassay result (or repeatedly reactive, if 
repeat testing is recommended by the manufacturer or required by regulatory authorities) should be 
tested with an FDA-approved antibody immunoassay that differentiates HIV-1 antibodies from HIV-2 
antibodies. Reactive results on the initial antigen/antibody combination immunoassay and the HIV-
1/HIV-2 antibody differentiation immunoassay should be interpreted as positive for HIV-1 antibodies, 
HIV-2 antibodies, or HIV antibodies, undifferentiated. 
3. Specimens that are reactive on the initial antigen/antibody combination immunoassay and nonreactive 
or indeterminate on the HIV-1/HIV-2 antibody differentiation immunoassay should be tested with an 
FDA-approved HIV-1 nucleic acid test (NAT). 
• A reactive HIV-1 NAT result and nonreactive HIV-1/HIV-2 antibody differentiation 
immunoassay result indicates laboratory evidence for acute HIV-1 infection. 
• A reactive HIV-1 NAT result and indeterminate HIV-1/HIV-2 antibody differentiation 
immunoassay result indicates the presence of HIV-1 infection confirmed by HIV-1 NAT. 
• A negative HIV-1 NAT result and nonreactive or indeterminate HIV-1/HIV-2 antibody 
differentiation immunoassay result indicates a false-positive result on the initial immunoassay.  
4. Laboratories should use this same testing algorithm, beginning with an antigen/antibody combination 
immunoassay, with serum or plasma specimens submitted for testing after a reactive (preliminary 
positive) result from any rapid HIV test.  
*  Exception: As of April 2014, data are insufficient to recommend use of the FDA-approved single-use rapid HIV-
1/HIV-2 antigen/antibody combination immunoassay as the initial assay in the algorithm. 
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Reporting results from the HIV diagnostic testing algorithm to persons ordering HIV tests and public health authorities 
Abbreviations: Ag/Ab, antigen/antibody; RNA, ribonucleic acid. 
Adapted from Interim Guidelines for Laboratories on the Use of a New Diagnostic Testing Algorithm for Human Immunodeficiency Virus (HIV) Infection. New York State 
Department of Health (http://www.health.ny.gov/diseases/aids/providers/regulations/testing/docs/guidelines_diagnostic_testing.pdf). 
Test performed Test results Final interpretation for provider report 
Test results to be reported to 
public health authorities 
1. HIV-1/2 Ag/Ab combination immunoassay 1. Nonreactive Negative for HIV-1 antigen and HIV-1/HIV-2 antibodies. 
No laboratory evidence of HIV infection. If acute HIV 
infection is suspected, consider testing for HIV-1 RNA. 
Reporting this test result is not 
required. 
1. HIV-1/2 Ag/Ab combination immunoassay 
2. HIV-1/HIV-2 antibody differentiation immunoassay 
1. Reactive 
2. HIV-1 reactive and HIV-2 nonreactive 
Positive for HIV-1 antibodies. Laboratory evidence 
consistent with established HIV-1 infection is present. 
Report test results 1 and 2. 
1. HIV-1/2 Ag/Ab combo immunoassay 
2. HIV-1/HIV-2 antibody differentiation immunoassay 
1. Reactive 
2. HIV-1 nonreactive and HIV-2 reactive 
Positive for HIV-2 antibodies. Laboratory evidence of 
HIV-2 infection is present. 
Report test results 1 and 2. 
1. HIV-1/2 Ag/Ab combination immunoassay 
2. HIV-1/HIV-2 antibody differentiation immunoassay 
3. HIV-1 RNA assay 
1. Reactive 
2. Nonreactive or indeterminate 
3. RNA not detected 
HIV antibodies were not confirmed and HIV-1 RNA was 
not detected. No laboratory evidence of HIV-1 infection. 
Follow-up testing for HIV-2 should be performed if 
clinically indicated.  
Reporting this test result is not 
required. 
1. HIV-1/2 Ag/Ab combination immunoassay 
2. HIV-1/HIV-2 antibody differentiation immunoassay 
3. HIV-1 RNA assay 
1. Reactive 
2. Nonreactive 
3. RNA detected 
Positive for HIV-1. Laboratory evidence consistent with 
acute HIV-1 infection is present. 
Report test results 1, 2, and 3. 
1. HIV-1/2 Ag/Ab combination immunoassay 
2. HIV-1/HIV-2 antibody differentiation immunoassay 
3. HIV-1 RNA assay 
1. Reactive 
2. Indeterminate 
3. RNA detected 
Positive for HIV-1 antibodies. Laboratory evidence of 
HIV-1 infection confirmed by HIV-1 RNA. 
Report test results 1, 2, and 3. 
1. HIV-1/2 Ag/Ab combination immunoassay 
2. HIV-1/HIV-2 antibody differentiation immunoassay 
1. Reactive 
2. HIV-1 and HIV-2 reactive  
Positive for HIV antibodies. Laboratory evidence of HIV 
infection is present. HIV antibodies could not be 
differentiated as HIV-1 or HIV-2. Additional testing for 
HIV-1 RNA or HIV-2 RNA should be performed if 
clinically indicated. 
Report test results 1 and 2. 
1. HIV-1/2 Ag/Ab combination immunoassay 
2. HIV-1/HIV-2 antibody differentiation immunoassay 
1. Reactive 
2. Nonreactive or indeterminate 
HIV-1 antibodies were not confirmed and HIV-1 
RNA testing was not performed. Testing of this specimen 
is incomplete. Follow-up testing for HIV antibodies and 
HIV-1 RNA is recommended as soon as possible. 
Report test results 1 and 2. 
